This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Konishi, H. Articles by Takahashi, T. Search for Related Content PubMed PubMed Citation Articles by Konishi, H. Articles by Takahashi, T.

Identification of Frequent G₂ Checkpoint Impairment and a Homozygous Deletion of 14-3-3 at 17p13.3 in Small Cell Lung Cancers¹

Division of Molecular Oncology, Aichi Cancer Center Research Institute, Kanokoden, Chikusa-ku, Nagoya 464-8681 [H. K., T. N., T. H., K. M., H. S., A. M., H. O., T. T.], and Department of Surgery, Osaka University Graduate School of Medicine, Yamadaoka, Suita 565-0871 [H. K., H. M.], Japan

Accumulating evidence suggests that a coordinately controlled G₂ checkpoint prevents cells with damaged DNA from entering mitosis, thus playing an important role in the maintenance of chromosomal integrity. In the study presented here, we identified a homozygous deletion of the 14-3-3 gene, which resides within a previously identified, commonly deleted region at 17p13.3 in lung cancers, in two small cell lung cancer cell lines that originate from distinct metastatic sites of the same patients. The introduction of 14-3-3 induced significantly restored G₂ checkpoint responses, which resulted in the reduction of mitotic cells as well as of aberrant mitotic figures in the X-ray-irradiated 14-3-3-null small cell lung cancer cell line. Interestingly, we also found that the G₂ checkpoint response is frequently impaired to various degrees in a large fraction of small cell lung cancer cell lines. These findings suggest the possible involvement of the perturbed G₂ checkpoint in the pathogenesis of this aggressive form of human lung cancers.

This article has been cited by other articles:

				L. Hu, Y. T. Zhu, C. Qi, and Y.-J. Zhu Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development Cancer Res., May 1, 2009; 69(9): 4067 - 4072. [Abstract] [Full Text] [PDF]

				H. Ebi, K. Matsuo, N. Sugito, M. Suzuki, H. Osada, K. Tajima, R. Ueda, and T. Takahashi Novel NBS1 Heterozygous Germ Line Mutation Causing MRE11-Binding Domain Loss Predisposes to Common Types of Cancer Cancer Res., December 1, 2007; 67(23): 11158 - 11165. [Abstract] [Full Text] [PDF]

				J. Xing, M. R. Spitz, C. Lu, H. Zhao, H. Yang, W. Wang, D. J. Stewart, and X. Wu Deficient G2-M and S Checkpoints are Associated with Increased Lung Cancer Risk: A Case-Control Analysis Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1517 - 1522. [Abstract] [Full Text] [PDF]

				S. A. Belinsky, D. M. Klinge, J. D. Dekker, M. W. Smith, T. J. Bocklage, F. D. Gilliland, R. E. Crowell, D. D. Karp, C. A. Stidley, and M. A. Picchi Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer Risk Clin. Cancer Res., September 15, 2005; 11(18): 6505 - 6511. [Abstract] [Full Text] [PDF]

				J.-i. Satoh, T. Yamamura, and K. Arima The 14-3-3 Protein {epsilon} Isoform Expressed in Reactive Astrocytes in Demyelinating Lesions of Multiple Sclerosis Binds to Vimentin and Glial Fibrillary Acidic Protein in Cultured Human Astrocytes Am. J. Pathol., August 1, 2004; 165(2): 577 - 592. [Abstract] [Full Text] [PDF]

				T. Nakagawa, Y. Hayashita, K. Maeno, A. Masuda, N. Sugito, H. Osada, K. Yanagisawa, H. Ebi, K. Shimokata, and T. Takahashi Identification of Decatenation G2 Checkpoint Impairment Independently of DNA Damage G2 Checkpoint in Human Lung Cancer Cell Lines Cancer Res., July 15, 2004; 64(14): 4826 - 4832. [Abstract] [Full Text] [PDF]

				J. Litz, P. Carlson, G. S. Warshamana-Greene, S. Grant, and G. W. Krystal Flavopiridol Potently Induces Small Cell Lung Cancer Apoptosis during S Phase in a Manner That Involves Early Mitochondrial Dysfunction Clin. Cancer Res., October 1, 2003; 9(12): 4586 - 4594. [Abstract] [Full Text] [PDF]